CLCécile Lambe

Cécile Lambe

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Cécile Lambe has a total of 109 co-authors. Here are the top co-authors by number of shared publications:

  • Olivier Goulet

    Department of Pediatric Gastroenterology, Necker Hospital, Paris-Cité University - AP-HP, Paris, France

    8 shared publications
  • Cécile Talbotec

    Department of Pediatric Gastroenterology, Necker Hospital, Paris-Cité University - AP-HP, Paris, France

    4 shared publications
  • Olivier Goulet

    Hôpital Necker-Enfants Malades, University Paris Cité Sorbonne Paris Descartes Medical School

    3 shared publications
  • Bénédicte Pigneur

    Service de Gastro‐entérologie et Nutrition pédiatrique, Centre de Référence Des Maladies Rares Digestives (MARDI), assistance Publique – Hôpitaux de Paris, Hôpital Necker Enfants Malades Université Paris Cité Paris France

    2 shared publications
  • Elie Abi Nader

    Service de Gastro-entérologie et Nutrition pédiatrique, Université Paris Cité, Hôpital Necker-Enfants Malades, Paris

    2 shared publications
  • Elie Abi Nader

    Division of Pediatric Gastroenterology, Hepatology and Nutrition, Necker-Enfants Malades University of Paris-UFR Paris Descartes, Certified Center for Home Parenteral Nutrition, Reference Center for Rare Digestive Diseases in Children, Paris, France

    2 shared publications

Latest Publications

  • Open Access

    Long-term outcomes after total colonic aganglionosis: retrospective European multicentre cohort study

    by Annika Mutanen, Alessio Pini Prato, Marta Erculiani, Cécile Lambe, Judith Lindert, Stefanie Märzheuser, Fabio Fusaro, Kjetil Juul Stensrud, Kristin Bjornland, Niels Qvist, et al.

    Background: Total colon aganglionosis (TCA), a severe form of Hirschsprung disease, is a rare and complex condition with variable management and limited outcome data. This retrospective cross-sectional multicentre study assessed current long-term outcomes of TCA in Europe. Methods: Patients with TCA under follow up at participating ERNICA and ESPGHAN centres were included. Data were collected on genetics, nutritional, functional, and surgical outcomes, intestinal inflammatory lesions, and mortality during the preceding 10 years. Results: Thirty-one centres from 15 countries contributed 401 patients (median age 7.9 years; interquartile range 4.0–13.6 years). Genetic testing was performed in 52% of patients, with pathogenic variants identified in 62%, mainly RET. Aganglionosis was limited to the colon in 26%, extended to the small bowel in 71%, and was total intestinal in 3%, without association with genetic status. At the latest follow-up, 25% of patients were receiving parenteral nutrition (PN); PN dependency was associated with small intestine extension of aganglionosis > 50 cm (72% of patients with >50 cm small bowel aganglionosis versus 15% of patients aganglionosis <50 cm small bowel or limited to the colon; P < 0.001). Overall, 77% of patients underwent pull-through, most commonly ileoanal anastomosis (62%) or Duhamel (31%). Complications included anastomotic leak (4%), strictures (12%), redo surgery (24%), recurrent enterocolitis (36%), obstructive symptoms (24%), and faecal incontinence (25%). Recurrent enterocolitis was associated with obstructive symptoms (P = 0.007). Endoscopy showed intestinal inflammatory lesions in 22% of patients, particularly those with recurrent enterocolitis (odds ratio (OR) 6.43; 95% confidence interval (c.i.) 3.27 to 12.63) and obstructive symptoms (OR 2.64; 95% c.i. 1.26 to 5.53). The 10-year mortality rate was 3.4%. Conclusion: TCA shows a high prevalence of genetic abnormalities and substantial postoperative and long-term morbidity, independent of surgical technique.

  • Open Access

    Histogenetic Classification Predicts Outcomes in 130 Adults With Chronic Intestinal Pseudo-Obstruction

    by Minh-Chau Ta, Dominique Cazals-Hatem, Lore Billiauws, Aurélien Amiot, Marc Bellaiche, Dominique Berrebi, Benoit Coffin, Olivier Corcos, Emmanuelle Ecochard-Dugelay, Olivier Goulet, et al.

    INTRODUCTION: Chronic intestinal pseudo-obstruction (CIPO) is a rare, heterogeneous disorder associated with severe morbidity. Genetic variants and histopathological lesions have been described, but their combined evaluation has rarely been assessed in adult CIPO cohorts. This study aimed to evaluate the contribution of integrated genetic and histological analyses in adults with CIPO. METHODS: We conducted a retrospective observational study of adults with CIPO followed at a national tertiary referral center. Patients with CIPO underwent genomic profiling, including next-generation sequencing (NGS) panel, long-range polymerase chain reaction (PCR), whole-exome, and whole-genome sequencing. Centralized histological analysis of full-thickness bowel biopsies and resections was integrated with genomic data to assess their combined impact on disease outcomes. RESULTS: The cohort included 130 patients (75 females, 55 males, aged 19–74 years), followed for up to 64 years. Genetic and histological analyses characterized 82% of the patients (genetic diagnosis: n = 65/112, 58%; histological diagnosis: n = 73/96, 76%), allowing the classification of patients into 6 groups: monogenic myopathy (n = 42), mitochondriopathy (n = 19), unspecified myopathy (n = 26), autoimmune myopathy (n = 8), neuropathy (n = 9), and others (n = 26). Survival and postoperative outcomes differed across groups. In this cohort, patients with monogenic myopathy had the most favorable long-term survival (adjusted hazard ratio: 0.06, 95% CI: 0.01–0.42; P = 0.004) and higher rates of improvement after bowel resection compared with other patients. DISCUSSION: Integrated genetic and histological evaluation informed etiological classification in adults with CIPO and may aid clinical decision-making.


  • Netherton syndrome: growth and endocrine assessment in a retrospective study of 37 paediatric patients

    by Nathalia Bellon, Alice Clerc, Pauline Bataille, Cécile Lambe, Fabienne Charbit-Henrion, Graziella Pinto, Christine Bodemer

    In this large retrospective cohort study of children with the syndromic epidermal differentiation disorder (sEDD) Netherton syndrome (now known as SPINK5-sEDD), we have further described the endocrine complications, as well as the frequency of growth hormone resistance, corticotropic insufficiency and rickets, thereby informing the need for systematic screening.

  • Intestinal Failure in Childhood

    by Olivier Goulet, Cécile Lambe

  • Long-term treatment with teduglutide: a 48-week open-label single-center clinical trial in children with short bowel syndrome

    by Cécile Lambe, Cécile Talbotec, Nathalie Kapel, Laurence Barbot-Trystram, Séverine Brabant, Elie Abi Nader, Bénédicte Pigneur, Elise Payen, Olivier Goulet


  • Erythrocyte fatty acid membrane composition in children on long-term parenteral nutrition enriched with ω-3 fatty acids

    by Olivier Goulet, Antonin Lamazière, Elie Abi Nader, Cécile Talbotec, Claude Wolf, Cécile Lambe

    Composite lipid emulsions containing soybean oil (30%), medium-chain triglycerides (30%), olive oil (25%), and fish oil (15%) (SMOF) are now widely used. We aimed to evaluate the tolerance, the efficiency, and the erythrocyte fatty acid (FA) profile for children on long-term home parenteral nutrition (HPN) receiving a composite fish oil-based emulsion (FOLE). At baseline, children (n = 46) with severe intestinal failure highly dependent on parenteral nutrition (PN) for ≥1 y were included in the study when they had received the composite FOLE for >6 mo. Out of this baseline group, only 25 children remained highly PN-dependent (SMOF1, n = 25) and could be assessed a second time, 2.4 y later (SMOF2, n = 25). An independent control group ("weaned off PN" group; n = 24) included children who had been weaned off PN for >2 y (median: 4 y). RBC-FA composition was established by GC-MS. Growth parameters, plasma citrulline, conjugated bilirubin, FA profiles, and the Holman ratio (20:3ω-9/20:4ω-6) were compared between groups. No difference for growth parameters, citrulline, and bilirubin was observed between the SMOF groups after 2.4 y (0.2 < P < 0.8). The weaned-off group did not differ from the SMOF groups for growth parameters (0.2 < P < 0.4) but citrulline was higher (P < 0.0001) and conjugated bilirubin lower (P < 0.01). The composite FOLE induced higher proportions of EPA (20:5n-3) (8.4% ± 2.9%) and DHA (22:6n-3) (11.7% ± 2.2%) than what was observed in weaned-off children (0.8% ± 0.4% and 6.6% ± 2.3%, respectively) but lower proportions of arachidonic acid (20:4n-6). However, the Holman ratio did not vary between groups (P = 0.9), whereas the PUFA concentrations varied widely. Long-term use of the composite FOLE was well tolerated in HPN-dependent children. The RBC-FA profile alterations were consistent with the ω-3 PUFA-enriched composition of this emulsion without evidence of essential FA deficiency.


  • Short Bowel Syndrome

    by Cecile Lambe, Olivier Goulet


  • The prevalence of feeding difficulties and potential risk factors in pediatric intestinal failure: Time to consider promoting oral feeds?

    by Dana Liza Boctor, Wiem Hassen Jutteau, Tanis R. Fenton, Jasmine Shourounis, Gary Joshua Galante, Isabelle Eicher, Olivier Goulet, Cecile Lambe


  • Pediatric Home Parenteral Nutrition in France: A six years national survey

    by Olivier Goulet, Anne Breton, Marie-Edith Coste, Béatrice Dubern, Emmanuelle Ecochard-Dugelay, Dominique Guimber, Irène Loras-Duclaux, Elie Abi Nader, Evelyne Marinier, Noel Peretti, et al.


  • Open Access

    Beyond 10 years, with or without an intestinal graft: Present and future?

    by Sophie Courbage, Danielle Canioni, Cécile Talbotec, Cécile Lambe, Christophe Chardot, Marion Rabant, Louise Galmiche, Olivier Corcos, Olivier Goulet, Francisca Joly, et al.